FINCH THERAPEUTICS GROUP INC (FNCH)
US31773D2009 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -74.75M | -114.65M | -58.16M | -39.34M | -20.75M | |||
| Depreciation Amortization | 1.52M | 5.51M | 2.30M | 790.00K | 480.00K | |||
| Income Taxes - Deferred | -3.46M | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -5.42M | -1.56M | -14.51M | 4.11M | 2.21M | |||
| Interest Paid | 202.00K | 740.00K | 10.00K | 10.00K | 10.00K | |||
| Other non cash items | 50.61M | 35.85M | 3.24M | 3.11M | 750.00K | |||
| OPERATING CASH FLOW | -31.50M | -74.85M | -67.13M | -31.33M | -17.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -2.18M | -15.98M | -2.63M | -1.01M | |||
| Other Investing Activity | 1.33M | 0.00 | 60.00K | 0.00 | 30.00K | |||
| INVESTING CASH FLOW | 1.33M | -2.18M | -15.92M | -2.63M | -970.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -15.00M | 14.72M | -30.00K | 1.76M | 4.73M | |||
| Stock Issued/Repurchased | 0.00 | 290.00K | 118.75M | 89.96M | 48.57M | |||
| Other Financing Activity | -1.16M | -130.00K | 390.00K | -250.00K | 0.00 | |||
| FINANCING CASH FLOW | -16.16M | 14.87M | 119.11M | 91.48M | 53.30M | |||
| CHANGE IN CASH | -46.33M | -62.16M | 36.06M | 57.52M | 35.01M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -31.50M | -74.85M | -67.13M | -31.33M | -17.32M | |||
| Capital Expenditure | 0.00 | -2.18M | -15.98M | -2.63M | -1.01M | |||
| FREE CASH FLOW | -31.50M | -77.03M | -83.11M | -33.96M | -18.33M | |||
All data in USD